Every 10-Q that Evolv Technologies Holdings, Inc. (EVLV) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow EVLV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EVLV filings page.
Evolv Technologies Holdings, Inc. reported higher revenue and narrower losses for the three and six months ended June 30, 2026. Total revenue for the first half of 2026 was $90.1 million, up from $64.6 million, driven mainly by growth in subscription revenue to $47.9 million and product revenue to $22.5 million. Gross profit rose to $45.6 million, reflecting scale across product, subscription, and services.
Operating expenses for the first half were $64.6 million versus $67.3 million, with lower general and administrative costs and no 2025‑type restructuring charges, leading to a reduced loss from operations of $19.0 million. Net loss for the first half improved to $14.3 million from $42.2 million, or $0.08 per share versus $0.26. Operating activities generated $8.7 million of cash, compared with a small outflow a year earlier.
As of June 30, 2026, Evolv held $62.6 million in cash, cash equivalents and marketable securities, with $30.0 million of term debt outstanding and additional borrowing capacity under its $75.0 million Senior Secured Credit Facilities. Deferred revenue was $92.2 million and remaining performance obligations totaled $312.6 million, supporting future subscription visibility. The company remains in compliance with its ARR and liquidity covenants but continues to expect losses as it invests for growth and manages ongoing class‑action and derivative settlements and an SEC inquiry.
Evolv Technologies Holdings reported first-quarter 2026 revenue of $46.3 million, up from $32.0 million a year earlier, driven by product, subscription, and service growth. The company recorded a net loss of $5.0 million, compared with a $1.7 million loss in 2025, as operating expenses and non-cash items offset higher gross profit.
Cash, cash equivalents, and marketable securities totaled $61.1 million as of March 31, 2026, with $30.0 million of term debt outstanding and an additional $45.0 million available under its credit facilities. Management believes this liquidity, plus expected cash from operations, will fund at least 12 months of needs.
The company remains in compliance with financial covenants under its MidCap credit agreement, including an Annual Recurring Revenue requirement of $107.3 million. Evolv has a $15.0 million securities Class Action settlement preliminarily approved, largely covered by $14.3 million of expected insurance recovery, and has agreed in principle to settle related derivative suits through governance reforms funded by insurers.
Evolv Technologies (EVLV) reported Q3 results showing faster growth and improved losses. Total revenue was $42.9 million, up from $27.4 million a year ago, led by subscription revenue of $22.7 million, service revenue of $7.8 million, product revenue of $9.2 million, and license/other revenue of $3.1 million. Gross profit rose to $21.3 million. The company posted a net loss of $1.8 million versus a $30.4 million loss last year, reflecting lower operating expenses and favorable fair value adjustments.
Liquidity improved with positive operating cash flow of $3.1 million for the nine months. Cash, cash equivalents, and marketable securities were $56.2 million as of September 30, 2025. Evolv entered a new $75.0 million senior secured credit facility, drawing $30.0 million, leaving $45.0 million available. Deferred revenue increased to $96.4 million, and annual recurring revenue was $117.2 million as of September 30, 2025. Shares outstanding were 174,617,589 as of November 7, 2025.
Evolv Technologies (EVLV) reported a quarter marked by accounting restatements, ongoing legal and regulatory matters, and continued operating losses despite product launches and financing. The company restated prior-period condensed consolidated financial statements after an internal investigation found extra-contractual terms that affected revenue recognition and led to personnel changes. Evolv had $36.9 million in cash, cash equivalents, and marketable securities as of June 30, 2025, and expects that, together with expected cash from operations and borrowing availability under newly negotiated Senior Secured Credit Facilities, it has at least twelve months of liquidity. The company recorded a net loss of $42.2 million for the six months ended June 30, 2025, recognized restructuring charges related to a reduction in force, and disclosed material weaknesses in internal controls with an active remediation plan. Significant contingencies include shareholder class and derivative actions, FTC and SEC matters, and an estimated $15.0 million settlement accrual for the class action with an expected $14.0 million insurance recovery.